Influence of antecedent of hypertension in patients with acute coronary syndrome without ST elevation

被引:8
作者
Fácila, L
Bertomeu, V
Núñez, J
Sanchis, J
Bodí, V
Consuegra, L
Bosch, MJ
Roselló, A
Martínez, A
Blasco, ML
Llàcer, A
机构
[1] Univ Valencia, Hosp Clin, Serv Cardiol, E-46010 Valencia, Spain
[2] Univ Valencia, Hosp Clin, Serv Cuidados Intens, E-46010 Valencia, Spain
来源
MEDICINA CLINICA | 2006年 / 126卷 / 04期
关键词
hypertension; prognosis; myocardial ischemia; management; cardiovascular risk;
D O I
10.1157/13084019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND AND OBJECTIVE: There are few studies evaluating the effect of a previous history of hypertension on long term prognosis after an acute coronary syndrome, using the new definitions and incorporating new risk markers in the analysis. The aim of our study was to determinate if hypertensive patients differ from non-hypertensives in the epidemiological profile, clinical presentation, treatment prescribed at discharge and prognosis after admission with non ST segment elevation acute coronary syndrome. PATIENTS AND METHOD: A total of 1,029 consecutive patients admitted with high suspiction of non ST segment elevation acute coronary syndrome were evaluated. Prognostic variables were deter mined during admission (epidemiological and biochemical), as it was the discharge treatment. follow up. The primary endpoint was defined as all cause mortality at one year RESULTS: 65.8% (n = 677) of patients had hypertension. Hypertensive patients displayed a worst epidemiological and biochemical profile, and different discharge treatment. There were 139 (13.5%) deaths at one year follow up. The all cause mortality for non-hypertensive patients was 12.5% and for hypertensives 14.6% (p = NS). In the multivariate analysis (Cox regression) there were no differences in mortality between these groups. CONCLUSIONS: A previous history of hypertension is an important factor to explain differences in the presence of other risk factors or the treatment, but is not a mortality predictor.
引用
收藏
页码:121 / 124
页数:4
相关论文
共 25 条
[1]   Myocardial infarction redefined -: A consensus Document of the Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction [J].
Alpert, JS ;
Antman, E ;
Apple, F ;
Armstrong, PW ;
Bassand, JP ;
de Luna, AB ;
Beller, G ;
Breithardt, G ;
Chaitman, BR ;
Clemmensen, P ;
Falk, E ;
Fishbein, MC ;
Galvani, M ;
Garson, A ;
Grines, C ;
Hamm, C ;
Jaffe, A ;
Katus, H ;
Kjekshus, J ;
Klein, W ;
Klootwijk, P ;
Lenfant, C ;
Levy, D ;
Levy, RI ;
Luepker, R ;
Marcus, F ;
Näslund, U ;
Ohman, M ;
Pahlm, O ;
Poole-Wilson, P ;
Popp, R ;
Alto, P ;
Pyörälä, K ;
Ravkilde, J ;
Rehnquist, N ;
Roberts, W ;
Roberts, R ;
Roelandt, J ;
Rydén, L ;
Sans, S ;
Simoons, ML ;
Thygesen, K ;
Tunstall-Pedoe, H ;
Underwood, R ;
Uretsky, BF ;
Van de Werf, F ;
Voipio-Pulkki, LM ;
Wagner, G ;
Wallentin, L ;
Wijns, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (03) :959-969
[2]   Issues in early risk stratification for UA/NSTEMI [J].
Antman, EM ;
Corbalán, R ;
Huber, K ;
Jaffe, AS .
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2001, 3 (0J) :J6-J14
[3]   Chest pain units: State of the art of the management of patients with chest pain in the emergency department [J].
Bassan, R ;
Gibler, WB .
REVISTA ESPANOLA DE CARDIOLOGIA, 2001, 54 (09) :1103-1109
[4]   Short-term prognosis of patients admitted for probable acute coronary syndrome without ST-segment elevation.: Role of new myocardial damage markers and acute-phase reactants [J].
Bodí, C ;
Facila, L ;
Sanchis, J ;
Llácer, A ;
Núñez, J ;
Mainar, L ;
Gómez-Aldaraví, R ;
Monmeneu, JV ;
Blasco, ML ;
Sanjuan, R ;
Insa, L ;
Chorro, FJ .
REVISTA ESPANOLA DE CARDIOLOGIA, 2002, 55 (08) :823-830
[5]   Prognostic markers of non-ST elevation acute coronary syndromes [J].
Bodí, V ;
Sanchis, J ;
Llácer, A ;
Fácila, L ;
Núñez, J ;
Pellicer, M ;
Bertomeu, V ;
Ruiz, V ;
Chorro, FJ .
REVISTA ESPANOLA DE CARDIOLOGIA, 2003, 56 (09) :857-864
[6]   History of hypertension and enhanced thrombogenic activity in postinfarction patients [J].
Fadl, YY ;
Zareba, W ;
Moss, AJ ;
Marder, VJ ;
Sparks, CS ;
Watelet, LFM ;
Carroll, ER .
HYPERTENSION, 2003, 41 (04) :943-949
[7]   Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (The Global Registry of Acute Coronary Events [GRACE]) [J].
Goldberg, RJ ;
Currie, K ;
White, K ;
Brieger, D ;
Steg, PG ;
Goodman, SG ;
Dabbous, O ;
Fox, KAA ;
Gore, JM .
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (03) :288-293
[8]   Antecedent hypertension confers increased risk for adverse outcomes after initial myocardial infarction [J].
Haider, AW ;
Chen, L ;
Larson, MG ;
Evans, JC ;
Chen, MH ;
Levy, D .
HYPERTENSION, 1997, 30 (05) :1020-1024
[9]   Cardiac biomarkers for rapid evaluation of chest pain [J].
Hamm, CW .
CIRCULATION, 2001, 104 (13) :1454-1456
[10]   Important factors for the 10-year mortality rate in patients with acute chest pain or other symptoms consistent with acute myocardial infarction with particular emphasis on the influence of age [J].
Herlitz, J ;
Karlson, BW ;
Lindqvist, J ;
Sjölin, M .
AMERICAN HEART JOURNAL, 2001, 142 (04) :624-632